These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 10596998)

  • 21. The importance of aprotinin and pentoxifylline in preventing leukocyte sequestration and lung injury caused by protamine at the end of cardiopulmonary bypass surgery.
    Ege T; Arar C; Canbaz S; Cikirikcioglu M; Sunar H; Yuksel V; Duran E
    Thorac Cardiovasc Surg; 2004 Feb; 52(1):10-5. PubMed ID: 15002070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of site of venous protamine administration, previously alleged risk factors, and preoperative use of aspirin on acute protamine-induced pulmonary vasoconstriction.
    Comunale ME; Maslow A; Robertson LK; Haering JM; Mashikian JS; Lowenstein E
    J Cardiothorac Vasc Anesth; 2003 Jun; 17(3):309-13. PubMed ID: 12827577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of nitric oxide for treatment of pulmonary hypertensive crisis in a child after protamine administration.
    Sakhai H; Casta A
    J Cardiothorac Vasc Anesth; 2006 Oct; 20(5):719-21. PubMed ID: 17023297
    [No Abstract]   [Full Text] [Related]  

  • 24. Ketanserin in the treatment of protamine-induced pulmonary hypertension.
    van der Starre PJ; Solinas C
    Tex Heart Inst J; 1996; 23(4):301-4. PubMed ID: 8969033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparin removal after cardiopulmonary bypass in a patient with adverse reaction to protamine.
    Tevaearai HT; Jegger D; Mueller XM; Horisberger J; von Segesser LK
    Thorac Cardiovasc Surg; 1998 Oct; 46(5):303-4. PubMed ID: 9885123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The successful management of severe protamine-induced pulmonary hypertension using inhaled prostacyclin.
    Jerath A; Srinivas C; Vegas A; Brister S
    Anesth Analg; 2010 Feb; 110(2):365-9. PubMed ID: 19933533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of protamine to rapidly reverse anticoagulant effect of unfractionated heparin in patients undergoing percutaneous coronary intervention.
    Patel AA; White CM; Coleman CI
    Conn Med; 2007 Feb; 71(2):93-5. PubMed ID: 17393902
    [No Abstract]   [Full Text] [Related]  

  • 28. Absence of complement-mediated events after protamine reversal of heparin anticoagulation.
    Wakefield TW; Kirsh MM; Till GO; Brothers TE; Hantler CB; Stanley JC
    J Surg Res; 1991 Jul; 51(1):72-6. PubMed ID: 2067362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protamine dosing--the quandary continues.
    Hall RI
    Can J Anaesth; 1998 Jan; 45(1):1-5. PubMed ID: 9466018
    [No Abstract]   [Full Text] [Related]  

  • 30. Protamine-induced pulmonary venoconstriction in heparinized pigs.
    Hakim TS; Picone A; Oleary CE; Camporesi EM
    Anesth Analg; 1995 Jul; 81(1):38-43. PubMed ID: 7598279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toward a better understanding of the hemodynamic effects of protamine and heparin interaction.
    Stefaniszyn HJ; Novick RJ; Salerno TA
    J Thorac Cardiovasc Surg; 1984 May; 87(5):678-86. PubMed ID: 6717047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of methylprednisolone on complement activation during heparin neutralization.
    Loubser PG
    J Cardiovasc Pharmacol; 1997 Jan; 29(1):23-7. PubMed ID: 9007666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thromboxane mediation of pulmonary hemodynamic responses after neutralization of heparin by protamine in pigs.
    Conzen PF; Habazettl H; Gutmann R; Hobbhahn J; Goetz AE; Peter K; Brendel W
    Anesth Analg; 1989 Jan; 68(1):25-31. PubMed ID: 2910134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Life threatening cardiopulmonary failure in an infant following protamine reversal of heparin after cardiopulmonary bypass.
    Boigner H; Lechner E; Brock H; Golej J; Trittenwein G
    Paediatr Anaesth; 2001 Nov; 11(6):729-32. PubMed ID: 11696152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of protamine overdose on coagulation parameters as measured by the thrombelastograph.
    Khan NU; Wayne CK; Barker J; Strang T
    Eur J Anaesthesiol; 2010 Jul; 27(7):624-7. PubMed ID: 20485179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic hypotensive response to protamine following chronic inhibition of nitric oxide synthase in rats.
    Komatsu H; Enzan K; Matsuura S; Kurosawa S; Mitsuhata H
    Can J Anaesth; 1998 Dec; 45(12):1186-9. PubMed ID: 10051937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies for improving the functionality of an affinity bioreactor.
    Wang T; Yang Z; Emregul E; David A; Balthasar JP; Liang J; Yang VC
    Int J Pharm; 2005 Dec; 306(1-2):132-41. PubMed ID: 16246511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protamine and protamine reactions.
    Park KW
    Int Anesthesiol Clin; 2004; 42(3):135-45. PubMed ID: 15205644
    [No Abstract]   [Full Text] [Related]  

  • 39. Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?
    Teoh KH; Young E; Blackall MH; Roberts RS; Hirsh J
    J Thorac Cardiovasc Surg; 2004 Aug; 128(2):211-9. PubMed ID: 15282457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anaphylaxis to protamine during cardiovascular surgery].
    Madani H; Sadiki EO; Bouziane M; Amaarouch S; Madani M; Khatouf M
    Ann Pharm Fr; 2014 May; 72(3):143-5. PubMed ID: 24780829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.